Whole-Genome Analysis Reveals that Mutations in Inositol Polyphosphate Phosphatase-like 1 Cause Opsismodysplasia  by Below, Jennifer E. et al.
REPORT
Whole-Genome Analysis Reveals that Mutations
in Inositol Polyphosphate Phosphatase-like 1
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Opsismodysplasia is a rare, autosomal-recessive skeletal dysplasia characterized by short stature, characteristic facial features, and in
some cases severe renal phosphate wasting. We used linkage analysis and whole-genome sequencing of a consanguineous trio to
discover that mutations in inositol polyphosphate phosphatase-like 1 (INPPL1) cause opsismodysplasia with or without renal phosphate
wasting. Evaluation of 12 families with opsismodysplasia revealed that INPPL1mutations explain ~60% of cases overall, including both
of the families in our cohort with more than one affected child and 50% of the simplex cases.Opsismodysplasia (MIM 258480) is a rare skeletal dysplasia
with delayed bonematuration (from ‘‘opsismos,’’ Greek for
‘‘late’’).1–3 The clinical signs observed at birth include short
limbs, small hands and feet, relative macrocephaly with
a large anterior fontanel, and characteristic craniofacial
abnormalities including a prominent brow, depressed
nasal bridge, a small anteverted nose, and a relatively
long philtrum. Death secondary to respiratory failure
during the first few years of life was reported in the cases
originally described but the outcome is now known to be
highly variable withmultiple long-term survivors.3 Typical
radiographic findings include shortened long bones with
very delayed epiphyseal ossification, severe platyspondyly,
metaphyseal cupping, and characteristic abnormalities of
themetacarpals and phalanges. Recurrence within sibships
and incidence in consanguineous pedigrees suggest that
the mode of inheritance of opsismodysplasia is autosomal
recessive.1–6
To determine the genetic basis of opsismodysplasia, one
of two siblings with opsismodysplasia and severe hypo-
phosphatemia because of renal phosphate wasting (AII-1
in Table 1, Figures 1 and 2, and Figure S1 available online)
and his consanguineous parents were genotyped with
the HumanCytoSNP-12 DNA Analysis BeadChip, at nearly
300,000 single-nucleotide polymorphisms (SNPs). All
studies were approved by the institutional review boards
of the University of Washington and Seattle Children’s
Hospital and informed consent was obtained from partici-1Department of Genome Sciences, University of Washington, Seattle, WA 9819
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The Americpants or their parents. Self-reported Hispanic and Native
American ancestry was first confirmed with EIGENSTRAT.
Parametric linkage analysis by a fully penetrant rare reces-
sive model (f2 ¼ 1; q ¼ 0.0001) and allele frequencies esti-
mated from unrelated members of the HapMap CEPH,
European, Chinese, Japanese, and Mexican American pop-
ulations (Figure S2) was performed with ALLEGRO on an
approximately 0.2 cM SNP map in an 11 person pedigree
that included the consanguineous parents of the proband.
Ten genomic regions reached amaximum LOD score of 1.5
(Figure S3). Homozygosity mapping via PLINK and default
parameters (length ¼ 1 Mb, # SNPs [n] ¼ 100, density
[kb/SNP] ¼ 50, largest gap [kb] ¼ 1 Mb) detected six of
the regions also implicated via linkage analysis.
Next, whole-genome sequencing was performed on both
parents and the same affected sibling used in the linkage
studies. In brief, 1 mg of genomic DNA was subjected to
a series of shotgun library construction steps, including
fragmentation through acoustic sonication (Covaris),
end-polishing (NEBNext End Repair kit), A-tailing
(NEBNext dA Tailing kit), and ligation of 8 bp barcoded
sequencing adaptors (Enzymatics Ultrapure T4 Ligase).
Libraries were automatically size selected for fragments
350–550 bp in length with the automated PippinPrep
cartridge system, which provides for fine control over the
insert size and physically isolates each size fraction in
separate chambers. Prior to sequencing, the library was
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Table 1. Mutations and Clinical Findings of Individuals with Opsismodysplasia
Case identifier AII-1 AII-2 BII-1 CII-1 DII-1 EII-1 FII-1 FII-2 GII-2
Mutations
Exon (INNPL1) 17 17 7 7 intron 21 1 14 5 1 6 1 6 18
Nucleotide c.1976C>T c.1976C>T c.768_769del c.768_769del c.2415þ1G>A c.35dup c.1687_1691del c.545C>A c.24_39del c.753G>C c.24_39del c.753G>C c.2071C>T
Peptide p.Pro659Leu p.Pro659Leu p.Glu258Alafs*
45
p.Glu258Alafs*
45
NA p.Ala13Argfs*
62
p.Thr563Glyfs*
3
p.Ser182* p.Gly9Trpfs*
13
p.Gln251His p.Gly9Trpfs*
13
p.Gln251His p.Arg691Trp
GERP score 5.43 5.43 NA NA 5.52 NA NA NA NA 4.77 NA 4.77 3.7
Predicted effect missense missense frameshift frameshift splice site frameshift frameshift nonsense frameshift missense frameshift missense missense
Genotype homozygous homozygous homozygous heterozygous heterozygous heterozygous heterozygous homozygous heterozygous heterozygous heterozygous heterozygous homozygous
Inheritance maternal/
paternal
maternal/
paternal
maternal/
paternal
DNA
unavailable
maternal paternal NA NA NA maternal paternal maternal paternal maternal/
paternal
Clinical Findings
Ancestry Hispanic/
Native
American
Hispanic/
Native
American
European
American
European American ND Middle Eastern African American/ European
American
African American/ European
American
Middle
Eastern
Consanguineous
parents
1st cousins
once removed
1st cousins
once
removed
no no no 1st cousins no no 1st cousins
Prenatal findings none none short limbs
(3rd trimester)
short limbs at 26 weeks EGA,
polyhydramnios
short limbs at 18–20 weeks
EGA
oligohydram-nios none short limbs
at 20 weeks
short limbs
at 18.3 weeks,
severe
micromelia,
and bell-
shaped
thorax at
22 weeks
Birth length ND 46.5 cm 43.8 cm 45.7 cm 43 cm 49 cm 43.1 cm 47 cm NA
Birth weight 3,380 g 3,192 g 3,120 g 3,572 g 2,745 g 3,015 g 3,100 g 3,500 g NA
Birth OFC ND 35.6 cm 38.5 cm
(2 months)
ND 35.5 cm 35 cm ND 36.8 cm NA
Age at last
evaluation
8 years
8 months
2 years
9 months
19 months 16 months birth (34–35 weeks gestation) 3 years 24 years 18 years NA
Macrocephaly – þ (mild) relative relative relative – – – –
Large fontanel(s) þ þ þ ND ND þ þ þ þ
Prominent
forehead
þ þ (mild) þ þ – – þ þ þ
Tall forehead þ – þ þ – þ þ þ þ
Hypertelorism þ – – þ ND þ þ þ þ
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Table 1. Continued
Case identifier AII-1 AII-2 BII-1 CII-1 DII-1 EII-1 FII-1 FII-2 GII-2
Long palpebral
fissures
þ – – ND ND þ 90% – NA
Proptosis/shallow
orbits
þ – þ þ ND þ þ þ þ
Depressed
nasal root
þ þ þ ND þ þ þ þ þ (absent
nasal bone)
Short nose þ þ þ þ þ þ þ þ þ
Abnormal ears – – þ ND þ (low set) þ posteriorly rotated, upturned
lobules
– –
Respiratory
insufficiency
þ (ventilator
dependent)
þ (mild to
moderate)
respiratory
distress
recurrent pneumonia,
pulmonary hypertension,
restrictive lung disease
þ (ventilated
at birth)
þ restrictive lung disease,
temporary tracheostomy,
and ventilatory support for
severe pneumonia at age
3 years
very mild intermittent reactive
airway disease, obstructive
sleep apnea requiring T & A,
CPAP
NA
Short hands/feet þ þ þ þ þ þ þ þ þ
Soft and/or
doughy skin
þ þ – ND ND þ – – NA
Psychomotor
development
normal at
8.5 years
mild motor
delay
mild motor
delay, walked
at 18 months
wheelchair dependent, normal
intelligence
NA þ motor delay very mild motor delay NA
Hypophosphatemia þ – unknown þ ND þ þ resolved age 9 years þ resolved age 14 years NA
Renal phosphate
wasting
þ – unknown þ ND þ þ þ NA
DEXA scan
results
prepamidronate
whole body
at 4 years
0.419, lastly
at 8.5 years 0.58
right distal
femur at
6 months
0.289, at
3 years
0.672
(pamidronate 3
2 years)
ND osteopenia ND ND age 17 yr. L2-L4 T score
0.852 g/cm2
ND NA
Stature z scores 9.5 4.8 ND ND ND ND 3.5 SD ND ND
Other clinical
features
dilated
cardiomyop-
athy, hypoplastic
right kidney,
left bronchial
narrowing,
history of oral
aversion
requiring
GT feeds
ASD, asthma,
left main stem
bronchomala-
cia, dysphagia/
aspiration
requiring
GT feeds
inguinal hernia
repair, facial
asymmetry,
high arched
palate
ND died of respiratory
insufficiency at
1 week of age
after being taken
off ventilator
posterior cleft
palate,
micrognathia,
recurrent
aspiration
pneumonia,
difficulty
swallowing
requiring
NG tube,
partial
renal tubular
acidosis,
tracheomalacia
small, narrow thorax, mild
elbow and knee flexion
contractures, hyperopia,
mild systolic hypertension
mild elbow flexion
contractures, mild bilateral
low-frequency conductive
hearing loss
ND
(Continued on next page)
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Table 1. Continued
Case identifier AII-1 AII-2 BII-1 CII-1 DII-1 EII-1 FII-1 FII-2 GII-2
Radiographic Findings
Short long bones þ þ þ þ þ þ þ þ þ
Metaphyseal
irregularity
and/or cupping
þ þ þ þ þ þ þ þ þ
Bony
undermineralization
þ þ ND ND ND þ þ þ þ
Fractures þ – – – – þ þ (ribs age 3 year,
complication of
hypophosphatemic
rickets)
– –
Angulation of
the long bones
þ – – þ – – þ þ þ
Delayed epiphyseal
ossification
þ þ þ þ þ þ þ þ NA
Carpal ossification
pattern/bone age
3–6 months
at 6 years
3 months
newborn at
12 months
newborn at
20 months
newborn at
24 months
ND no ossification
at 3 years
15 years at
16 years
6 months
5 years 6 months at 9 years
6 months
NA
Short and square
metacarpals and
phalanges
þ þ þ þ þ þ þ þ þ
Other radiographic
features
ND calcaneal
spurs
calcaneal spurs,
odontoid
hypoplasia
calcaneal
spurs
ND small, irregular
middle
phalanges
with tapering
and periosteal
retraction
platyspondyly, small foramen
magnum, cervical spinal
canal stenosis from skull
base to C4, hypoplastic
square iliac wings and
pubic bones, coxa vara,
broad femoral heads,
acetabular dysplasia
(upsloping of
lateral acetabuli)
platyspondyly, small foramen
magnum, odontoid
hypoplasia, cervical spinal
canal stenosis from skull
base to C3, hypoplastic
square iliac wings, coxa vara
small and flat
vertebral
bodies,
lumbar
kyphosis,
narrow chest,
small and
cupped pubic
bones
Plus sign (þ) indicates presence of a finding, minus sign (–) indicates absence of a finding. Abbreviations: ND, no data available; NA, not applicable, GERP, Genomic Evolutionary Rate Profiling; Birth OFC, birth occipital-frontal
circumference; EGA, estimated gestational age; T & A, tonsillectomy and adenoidectomy; CPAP, continuous positive airway pressure; GT, gastrostomy tube; NG, nasogastric.
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Figure 1. Characteristic Physical Find-
ings in Children and Adults with Opsismo-
dysplasia
(A–D) Typical features of the face include
relative macrocephaly, a prominent fore-
head, and a short nose with a depressed
nasal bridge.
(E and F) Acquired abnormalities resulting
from undermineralization of the long
bones include bowing of the upper limb
(E) and/or lower limb (F).
Case identifiers: AII-1 (A, E, F), AII-2 (B),
FII-1 (C), and FII-2 (D), corresponding to
those in Table 1, where a detailed descrip-
tion of each individual is provided.flow-cell loading, the library concentration was deter-
mined by triplicate qPCR (Kapa Illumina Library Quantifi-
cation kit) and molecular weight distributions verified on
the Agilent Bioanalyzer. Massively parallel sequencing-
by-synthesis via fluorescently labeled, reversibly termi-
nating nucleotides was carried out on the HiSeq sequencer.
Samples were sequenced to at least 303 average depth with
paired-end 100 bp reads; a third read sequenced the 8 bp
index to confirm sample assignments.
Demultiplexed BAM files were aligned to a human
reference (hg19) with the Burrows-Wheeler Aligner.7Figure 2. Radiographs of Individual AII-1 at 2 Years and 11 Months of Age
(A) Lateral image of skull showing midface hypoplasia and underdevelopment of the maxil
(B) Anterior-posterior (AP) image of the pelvis showing decreased mineralization, dislocated
normal architecture of the proximal femurs.
(C and E) AP image of the chest notable for under mineralization of the vertebrae and platy
(D) The metacarus, metatarsus, and all of the phalanges are short and irregular with flared m
(F and G) Delayed mineralization and absence of growth centers in the upper (F) and lower
The American Journal of Human GeRead data from a flow-cell lane were
treated independently for alignment
and QC purposes in instances where
the merging of data from multiple
lanes was required. All aligned
read data were subjected to (1) re-
moval of duplicate reads, (2) indelrealignment by the GATK IndelRealigner, and (3)
base qualities recalibration via GATK TableRecalibration.
Variant detection and genotyping were performed with
the UnifiedGenotyper (UG) tool from GATK (refv1.529).
Variant data for each sample were formatted (variant call
format [VCF]) as ‘‘raw’’ calls that contained individual
genotype data for one or multiple samples and flagged
with the filtration walker (GATK) to mark sites that were
of lower quality and potential false positives (e.g., quality
scores [%50], allelic imbalance [R0.75], long homopol-
ymer runs [>3], and/or low quality by depth [QD < 5]).la.
hips, poorly formed acetabula, and loss of
spondyly.
etaphyses.
(G) limbs.
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p.Gln251His
1 5432 76 1311 12 14 232115 16 17 18 2624 2522 2719 20 28
p.Ser182*
p.Glu258Alafs*45
p.Pro659Leu
1098
c.2415+1 G >A
p.Thr563Glyfs*3
p.Ala13Argfs*62
†
p.Arg691Trpp.Gly9Trpfs*13
Figure 3. Genomic Structure and Allelic Spectrum of INPPL1 Mutations that Cause Opsismodysplasia
INPPL1 is composed of 28 exons that encode untranslated regions (orange) and protein coding sequence (blue) domains including SH2
(red), catalytic (yellow), a proline-rich region (orange), ubiquitin-interacting region (light blue), and SAM (green). Arrows indicate the
locations of nine different mutations found in seven families with opsismodysplasia. Inverted hatch mark indicates recurrent mutation.Variant data were annotated with the SeattleSeq Annota-
tion Server.
Regions under linkage peaks covering a total of ~157 Mb
were examined for rare and/or novel functional variation
including missense, nonsense, splice site mutations, and
indels. In the proband (AII-1), novel, homozygous
missense mutations for which both parents were heterozy-
gous were identified in five genes (INPPL1 [MIM 600829],
VPS13A [MIM 605978], PRKDC [MIM 600899], NEU3
[MIM 604617], and CARNS1 [MIM 613368]; RefSeq
NM_001567.3). Sanger sequencing of these variants in
the affected sister of the proband (AII-2) revealed that she
was homozygous only for variants in INPPL1, NEU3, and
CARNS1, thus reducing the number of candidate genes to
three. These candidates were further prioritized based on
their putative biological function and screened via Sanger
sequencing in an unrelated family with a single child
with opsismodysplasia. In the first gene screened, INPPL1,
the affected child (EII-1 in Table 1), who was the product of
a consanguineous mating, was found to be homozygous
for a nonsense mutation (c.545C>A [p.Ser182*]).
To determine the extent to which INPPL1 mutations
explain cases of opsismodysplasia, we used Sanger
sequencing to screen ten additional unrelated families
(total of ten affected individuals and the unaffected
parents of a deceased child from whom a DNA sample
was unavailable). These families consisted of nine trios
in which an affected child was born to unaffected parents
and one additional family with two affected siblings.
Collectively, between the two families used for discovery
and our validation studies, INPPL1 mutations were found
in 7/12 (58%) kindreds tested (Table 1), including both
families with more than one individual affected and
5/10 (50%) of the simplex cases. In each of the five fami-
lies for which DNA was available from one or both
parents, heterozygosity for the INPPL1 mutation was
found. No other genes that cause phenotypes similar to
opsismodysplasia were tested in the INPPL1 mutation-
negative cases.
A total of nine unique mutations were identified
including four frameshift, one nonsense, one splicing,142 The American Journal of Human Genetics 92, 137–143, January 1and three missense mutations (Table 1; Figure 3). None
of the INPPL1missense, nonsense, or splice site mutations
identified in the subjects were found in >13,000 chromo-
somes sequenced as part of the NHLBI-ESP. In three
families, the affected individual(s) was a compound
heterozygote. In four kindreds, including all three consan-
guineous families and one family that was not known to be
consanguineous, the affected individuals were homozy-
gous for an INPPL1 mutation. In the latter family (family
B in Figure S1), inheritance of the mutation from the
mother was confirmed, but the paternal sample was
unavailable for testing. It is possible that the father is
also a heterozygous carrier of this mutation, but a deletion
encompassing the region could not be ruled out. However,
this mutation (c.768_769del [p.Glu258Alafs*45]) was also
shared in a second unrelated family (family C in Figure S1)
of European ancestry, indicating that there may be a carrier
population with this variant.
Three of the frameshift mutations and the nonsense
mutation are predicted to lead to premature termination
codons at the 50 end of the transcript, suggesting that
they lead to loss of INPPL1 function. In particular, homo-
zygosity for the Ser182* mutation found in the index
case would eliminate most of the functional domains of
the protein, including the catalytic domain (Figure 3).
Thus, even if transcripts containing this mutation were
stable to nonsense-mediated decay, the resulting truncated
protein would be unlikely to retain significant function.
INPPL1 encodes inositol polyphosphate phosphatase-
like 1 or SHIP2, a secondary messenger that has multiple
roles in developmental processes including cellular prolif-
eration, adhesion, and migration and metabolic functions
such as glucose homeostasis and insulin signaling.8–10
Because of the role of SHIP2 in energy metabolism, it has
been intensely studied both in vitro and in animal models.
In mice, absence of SHIP2 protein or decreased expression
of a catalytically inactive SHIP2 results in multiple devel-
opmental defects including a shortened facial profile and
diminished growth.9,10 Specifically, the Inppl1/ mice
are about half the size of Inppl1þ/þ mice, suggesting that
the axial and appendicular skeleton must be affected.100, 2013
Inppl1 has been shown to be expressed at E14.5 in the
developing axial and appendicular skeletal elements
(Eurexpress), further supporting its role in skeletogenesis.
The mechanism by which loss of SHIP2 affects skeletal
development is unknown because, beyond its catalytic
function, SHIP2 has been shown to act as a docking
protein for many other cytoplasmic molecules.11
In summary, we used linkage analysis and whole-
genome sequencing of a consanguineous trio to discover
that mutations in INPPL1 cause opsismodysplasia and
explain ~60% of cases in our cohort. The clinical character-
istics of individuals with opsismodysplasia caused by
INPPL1 mutations were indistinguishable from those
without INPPL1 mutations and included both individuals
with severe renal phosphate wasting and those in whom
no such abnormality had been reported. This observation
suggests that opsismodysplasia is genetically heteroge-
neous. Our findings further support a role for SHIP2 in
the development of the craniofacial, axial, and appendic-
ular skeleton.10Supplemental Data
Supplemental Data include three figures and can be found with
this article online at http://www.cell.com/AJHG/.Acknowledgments
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